- Home
- ELAB
ELAB
Elevai Labs Inc.
as 11-11-2025 2:42pm EST
Stocks
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
Upcoming Earnings Alert:
Get ready for potential market movements as Elevai Labs Inc. ELAB prepares to release earnings report on 14 Nov 2025.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | NEWPORT BEACH |
| Market Cap: | 3.2M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 117.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -37.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.29 - $216.63 | Next Earning Date: | 11-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Elevai Labs Inc. News
ELAB Breaking Stock News: Dive into ELAB Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
NorthStrive® Companies Inc. Advises on the Successful Closing of the Acquisition of Indarg Engineering, Inc., a California-Based Precision CNC Manufacturer
GlobeNewswire
12 days ago
PMGC Holdings Inc. Announces AGA Precision Systems LLC’s ITAR (International Traffic in Arms Regulations) Registration Approval
MT Newswires
a month ago
Top Premarket Gainers
MT Newswires
5 months ago
PMGC Signs LOI to Acquire CNC Machining Firm; Shares Rise
GlobeNewswire
5 months ago
PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue
GlobeNewswire
5 months ago
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
TipRanks
5 months ago
Northstrive announces initiation of Phase II of AI Development Program
GlobeNewswire
5 months ago
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases
Compare ELAB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ELAB Elevai Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.